Spots Global Cancer Trial Database for Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Official Title: Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Study ID: NCT05930457
Conditions
Study Description
Brief Summary: This is the study of 64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
